Incannex Healthcare Inc (IXHL)
2.85
-0.14
(-4.68%)
USD |
NASDAQ |
May 31, 16:00
2.83
-0.02
(-0.70%)
After-Hours: 20:00
Incannex Healthcare Net Income (Quarterly): -6.031M for March 31, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -6.031M |
December 31, 2023 | -5.241M |
June 30, 2023 | 31.41M |
Date | Value |
---|---|
March 31, 2023 | -3.571M |
December 31, 2022 | -2.918M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-6.031M
Minimum
Mar 2024
31.41M
Maximum
Jun 2023
2.730M
Average
-3.571M
Median
Mar 2023
Net Income (Quarterly) Benchmarks
Propanc Biopharma Inc | -0.5267M |
NovaBay Pharmaceuticals Inc | -3.214M |
Palatin Technologies Inc | -8.436M |
iBio Inc | -3.172M |
Theriva Biologics Inc | -5.165M |
Net Income (Quarterly) Related Metrics
Total Expenses (Quarterly) | 6.095M |
EPS Diluted (Quarterly) | -0.38 |
Enterprise Value | 35.93M |
Earnings Yield | 36.82% |